{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:08:44Z","timestamp":1789193324146,"version":"build-2803163510"},"reference-count":49,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ. Health Prev. Med.","Environ Health Prev Med"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1265\/ehpm.26-00078","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:11:33Z","timestamp":1789164693000},"page":"60-60","source":"Crossref","is-referenced-by-count":0,"title":["Impact of aldehyde dehydrogenase 2 polymorphism on lipid profile alterations in alcohol-abstinent adolescents stratified by steatotic liver disease status"],"prefix":"10.1265","volume":"31","author":[{"given":"Akira","family":"Kado","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"},{"name":"Division for Health Service Promotion, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"},{"name":"Division for Health Service Promotion, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[{"name":"Division of Infection Control and Prevention, Education Research Center, Tokyo Health Care University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeya","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Gastroenterology, Kanto Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Yanagimoto","sequence":"additional","affiliation":[{"name":"Division for Health Service Promotion, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","DOI":"10.1038\/nrgastro.2017.109"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li J, Zou B, Yeo YH, Feng Y, Xu Z, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389\u201398.","DOI":"10.1016\/S2468-1253(19)30039-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kado A, Inoue Y, Moriya K, Tsutsumi T, Ikeuchi K, Okushin K, et al. Triglyceride level and soft drink consumption predict nonalcoholic fatty liver disease in nonobese male adolescents. Hepatol Res. 2023;53:497\u2013510.","DOI":"10.1111\/hepr.13889"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rinella ME, Lazarus JV, Ratziu V, Francque S, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","DOI":"10.1097\/HEP.0000000000000696"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kamada Y, Takahashi H, Shimizu M, Kawaguchi T, Sumida Y, Fujii H, et al. Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. J Gastroenterol. 2021;56:1045\u201361.","DOI":"10.1007\/s00535-021-01833-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sookoian S, Casta\u00f1o GO, Scian R, Mallardi P, Fern\u00e1ndez Gianotti T, Burgue\u00f1o AL, et al. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology. 2015;61:515\u201325.","DOI":"10.1002\/hep.27556"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53:1883\u201394.","DOI":"10.1002\/hep.24283"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Honda Y, Yoneda M, Kessoku T, Ogawa Y, Tomeno W, Imajo K, et al. Characteristics of non-obese non-alcoholic fatty liver disease: effect of genetic and environmental factors. Hepatol Res. 2016;46:1011\u20138.","DOI":"10.1111\/hepr.12648"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhong S, Li L, Liang N, Zhang L, Xu X, Chen S, et al. Acetaldehyde dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox Biol. 2021;41:101919.","DOI":"10.1016\/j.redox.2021.101919"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Karunakaran U, Elumalai S, Chung SM, Maedler K, Won KC, Moon JS. Mitochondrial aldehyde dehydrogenase-2 coordinates the hydrogen sulfide\u2013AMPK axis to attenuate high glucose-induced pancreatic \u03b2-cell dysfunction by glutathione antioxidant system. Redox Biol. 2024;69:102994.","DOI":"10.1016\/j.redox.2023.102994"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kogiso T, Sagawa T, Kodama K, Taniai M, Tokushige K, Hashimoto E, et al. Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases. Ann Hepatol. 2021;21:100260.","DOI":"10.1016\/j.aohep.2020.09.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Oniki K, Morita K, Watanabe T, Kajiwara A, Otake K, Nakagawa K, et al. The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease. Nutr Diabetes. 2016;6:e210.","DOI":"10.1038\/nutd.2016.17"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xu Z, Gao Y, Yu Z, Zhang R, Wang R, Li S, et al. Transcriptome analysis of liver injury of fatty liver disease induced by ALDH2 deficiency. Sci Rep. 2025;15:2487.","DOI":"10.1038\/s41598-025-86547-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. GBD Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:1015\u201335.","DOI":"10.1016\/S0140-6736(18)31310-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kado A, Moriya K, Inoue Y, Yanagimoto S, Tsutsumi T, Koike K, et al. Decreased antioxidant-related superoxide dismutase 1 expression in peripheral immune cells indicates early ethanol exposure. Sci Rep. 2024;14:25091.","DOI":"10.1038\/s41598-024-76084-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al. Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 2024;10:eade2780.","DOI":"10.1126\/sciadv.ade2780"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Huang L, Cai X, Lian F, Zhang L, Kong Y, Cao C, et al. Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: a guide to targeted heart health management. Environ Health Prev Med. 2018;23:29.","DOI":"10.1186\/s12199-018-0719-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43:1\u201323.","DOI":"10.1016\/j.ecl.2013.09.009"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708\u201315.","DOI":"10.1111\/j.1572-0241.2007.01526.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156:1717\u201330.","DOI":"10.1053\/j.gastro.2019.01.042"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 1993;95:309\u201314.","DOI":"10.1016\/0002-9343(93)90284-V"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kado A, Tsutsumi T, Enooku K, Fujinaga H, Ikeuchi K, Okushin K, et al. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells. J Gastroenterol. 2019;54:730\u201341.","DOI":"10.1007\/s00535-019-01565-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kado A, Inoue Y, Tsutsumi T, Fujishiro M, Yanagimoto S. Genetic and lifestyle determinants of lipid profiles in Japanese young adults: evidence from MBOAT7 rs641738. Lipids Health Dis. 2026;25:156.","DOI":"10.1186\/s12944-026-02971-w"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Miyamori D, Tanaka Y, Ishikawa N, Kitamura T, Ikegaya H. Population history in Okinawa based on JC virus and ALDH2 genotypes. Sci Rep. 2020;10:7331.","DOI":"10.1038\/s41598-020-64194-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yamamoto K, Kogiso T, Taniai M, Hashimoto E, Tokushige K. Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease. JGH Open. 2019;3:17\u201324.","DOI":"10.1002\/jgh3.12097"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hu C. Aldehyde dehydrogenases genetic polymorphism and obesity: from genomics to behavior and health. Adv Exp Med Biol. 2019;1193:135\u201354.","DOI":"10.1007\/978-981-13-6260-6_8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tabara Y, Arai H, Hirao Y, Takahashi Y, Setoh K, Kawaguchi T, et al. The causal effects of alcohol on lipoprotein subfraction and triglyceride levels using a Mendelian randomization analysis: the Nagahama study. Atherosclerosis. 2017;257:22\u20138.","DOI":"10.1016\/j.atherosclerosis.2016.12.008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Suzuki T, Fukui S, Shinozaki T, Asano T, Yoshida T, Aoki J, et al. Lipid profiles after changes in alcohol consumption among adults undergoing annual checkups. JAMA Netw Open. 2025;8:e250583.","DOI":"10.1001\/jamanetworkopen.2025.0583"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nova E, Baccan GC, Veses A, Zapatera B, Marcos A. Potential health benefits of moderate alcohol consumption: current perspectives in research. Proc Nutr Soc. 2012;71:307\u201315.","DOI":"10.1017\/S0029665112000171"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. De Oliveira E Silva ER, Foster D, McGee Harper M, Seidman CE, Smith JD, Breslow JL, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation. 2000;102:2347\u201352.","DOI":"10.1161\/01.CIR.102.19.2347"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Cao YN, Yue SS, Wang AY, Xu L, Hu YT, Qiao X, et al. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity. J Ethnopharmacol. 2022;292:115146.","DOI":"10.1016\/j.jep.2022.115146"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Han S, Zhao X, Zhang X, Xu Y, Geng J, Wang Y. Acetaldehyde dehydrogenase 2 rs671 polymorphism affects hypertension susceptibility and lipid profiles in a Chinese population. DNA Cell Biol. 2019;38:962\u20138.","DOI":"10.1089\/dna.2019.4647"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takeno K, Tamura Y, Kakehi S, Kaga H, Kawamori R, Watada H. ALDH2 rs671 is associated with elevated FPG, reduced glucose clearance and hepatic insulin resistance in Japanese men. J Clin Endocrinol Metab. 2021;106:e3573\u201381.","DOI":"10.1210\/clinem\/dgab324"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wada M, Daimon M, Emi M, Iijima H, Sato H, Koyano S, et al. Genetic association between aldehyde dehydrogenase 2 (ALDH2) variation and high-density lipoprotein cholesterol (HDL-C) among non-drinkers in two large population samples in Japan. J Atheroscler Thromb. 2008;15:179\u201384.","DOI":"10.5551\/jat.E542"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhang J, Guo Y, Zhao X, Pang J, Pan C, Wang J, et al. The role of aldehyde dehydrogenase 2 in cardiovascular disease. Nat Rev Cardiol. 2023;20:495\u2013509.","DOI":"10.1038\/s41569-023-00839-5"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Li L, Zhong S, Li R, Liang N, Zhang L, Xia S, et al. Aldehyde dehydrogenase 2 and PARP1 interaction modulates hepatic HDL biogenesis by LXR\u03b1-mediated ABCA1 expression. JCI Insight. 2022;7:e155869.","DOI":"10.1172\/jci.insight.155869"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, Moon S, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020;582:240\u20135.","DOI":"10.1038\/s41586-020-2263-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Liu R, Peng M, Zhang J, Qiu K, Zeng T, Chen L. The ALDH2 gene rs671 polymorphism is associated with cardiometabolic risk factors in East Asian population: an updated meta-analysis. Front Endocrinol (Lausanne). 2024;15:1333595.","DOI":"10.3389\/fendo.2024.1333595"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hao PP, Xue L, Wang XL, Chen YG, Wang JL, Ji WQ, et al. Association between aldehyde dehydrogenase 2 genetic polymorphism and serum lipids or lipoproteins: a meta-analysis of seven East Asian populations. Atherosclerosis. 2010;212:213\u20136.","DOI":"10.1016\/j.atherosclerosis.2010.05.024"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Imatoh T, Yengo L, Rocheleau G, Kamimura S, Maeda S, Miyazaki M, et al. ALDH2 Polymorphism rs671, but Not ADH1B Polymorphism rs1229984, Increases Risk for Hypo-HDL-Cholesterolemia in a\/a Carriers Compared to the G\/G Carriers. Lipids. 2018;53:797\u2013807.","DOI":"10.1002\/lipd.12087"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Hidaka A, Sasazuki S, Matsuo K, Ito H, Sawada N, Shimazu T, et al. Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Carcinogenesis. 2015;36:223\u201331.","DOI":"10.1093\/carcin\/bgu244"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Zhong S, Li L, Zhang YL, Zhang L, Lu J, Guo S, et al. Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation. J Clin Invest. 2019;129:252\u201367.","DOI":"10.1172\/JCI122064"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Matsuse H, Shimoda T, Fukushima C, Mitsuta K, Kawano T, Tomari S, et al. Screening for acetaldehyde dehydrogenase 2 genotype in alcohol-induced asthma by using the ethanol patch test. J Allergy Clin Immunol. 2001;108:715\u20139.","DOI":"10.1067\/mai.2001.118791"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Forman D, Yang M, Chien R, Nguyen H, Wong C, Kim JHJ, et al. ALDH2 deficiency and alcohol intake in the United States: opportunity for precision cancer prevention. Cancer Epidemiol Biomarkers Prev. 2025;34:744\u201353.","DOI":"10.1158\/1055-9965.EPI-24-1296"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tsai MC, Yang SS, Lin CC, Wang WL, Hsu YC, Chen YS, et al. Association of heavy alcohol intake and ALDH2 rs671 polymorphism with hepatocellular carcinoma and mortality in patients with hepatitis B virus-related cirrhosis. JAMA Netw Open. 2022;5:e2223511.","DOI":"10.1001\/jamanetworkopen.2022.23511"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Golabi P, Paik J, Hwang JP, Wang S, Lee HM, Younossi ZM. Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. Liver Int. 2019;39:748\u201357.","DOI":"10.1111\/liv.14038"},{"key":"47","unstructured":"47. Japan National Nutrition Survey 2019. Tokyo: Ministry of Health, Labour and Welfare; 2019."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Tagaino R, Washio J, Abiko Y, Tanda N, Sasaki K, Takahashi N. Metabolic property of acetaldehyde production from ethanol and glucose by oral Streptococcus and Neisseria. Sci Rep. 2019;9:10446.","DOI":"10.1038\/s41598-019-46790-9"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Uebelacker M, Lachenmeier DW. Quantitative determination of acetaldehyde in foods using automated digestion with simulated gastric fluid followed by headspace gas chromatography. J Autom Methods Manag Chem. 2011;2011:907317.","DOI":"10.1155\/2011\/907317"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/31\/0\/31_26-00078\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:11:21Z","timestamp":1789189881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/31\/0\/31_26-00078\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.26-00078","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26-00078"}}